Joel Morganroth
#121,144
Most Influential Person Now
Joel Morganroth's AcademicInfluence.com Rankings
Joel Morganrothphilosophy Degrees
Philosophy
#5495
World Rank
#8312
Historical Rank
Logic
#2763
World Rank
#3800
Historical Rank
Joel Morganrothbiology Degrees
Biology
#7361
World Rank
#10273
Historical Rank
Physiology
#194
World Rank
#380
Historical Rank
Download Badge
Philosophy Biology
Joel Morganroth's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Physiology University of California, San Francisco
Why Is Joel Morganroth Influential?
(Suggest an Edit or Addition)Joel Morganroth's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comparative left ventricular dimensions in trained athletes. (1975) (758)
- Relation between Echocardiographically Determined Left Atrial Size and Atrial Fibrillation (1976) (623)
- Limitations of Routine Long-Term Electrocardiographic Monitoring to Assess Ventricular Ectopic Frequency (1978) (570)
- Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. (1984) (270)
- The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. (1975) (254)
- Immediate Diagnosis of Acute Myocardial Infarction by Two‐dimensional Echocardiography (1982) (240)
- Spontaneous Variability of Complex Ventricular Arrhythmias Detected by Long‐term Electrocardiographic Recording (1980) (238)
- Electrocardiographic left atrial enlargement. Electrophysiologic, echocardiographic and hemodynamic correlates. (1977) (226)
- Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives (2013) (199)
- Sudden death in hospitalized patients: cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. (1983) (194)
- Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia. (1991) (178)
- Quinidine‐Related Mortality in the Short‐to‐Medium‐Term Treatment of Ventricular Arrhythmias: A Meta‐Analysis (1991) (175)
- Type III hyperlipoproteinemia: an analysis of two contemporary definitions. (1975) (174)
- Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. (1980) (167)
- Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death. (1980) (164)
- Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. (1985) (163)
- Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study (2006) (158)
- Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. (1985) (156)
- Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide. (1986) (148)
- Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval) (2013) (139)
- Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability. (1996) (138)
- Two dimensional echocardiography in mitral, aortic and tricuspid valve prolapse. The clinical problem, cardiac nuclear imaging considerations and a proposed standard for diagnosis. (1980) (136)
- Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience. (1983) (135)
- Aspirin- and coumadin-related bleeding after coronary- artery bypass graft surgery. (1978) (135)
- Mitral annular calcification: clinical, pathophysiology, and echocardiographic review. (1984) (131)
- Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. (1972) (131)
- Postoperative arrhythmias after coronary artery and cardiac valvular surgery detected by long-term electrocardiographic monitoring. (1979) (130)
- Immediate detection of early high-risk patients with acute myocardial infarction using two-dimensional echocardiographic evaluation of left ventricular regional wall motion abnormalities. (1982) (127)
- Dealing with Global Safety Issues (2013) (127)
- Cardiovascular complaints. Correlation with cardiac arrhythmias on 24-hour electrocardiographic monitoring. (1980) (126)
- Risk factors for the development of proarrhythmic events. (1987) (124)
- Tyrosine Kinase Inhibitors: Their On-Target Toxicities as Potential Indicators of Efficacy (2013) (111)
- Exercise cross-sectional echocardiographic diagnosis of coronary artery disease. (1980) (111)
- Intramyocardial Conduction: A Major Determinant of R‐wave Amplitude During Acute Myocardial Ischemia (1982) (110)
- Determinants of ventricular septal motion. Influence of relative right and left ventricular size. (1976) (109)
- Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin. (1984) (105)
- Electrocardiographic Identification of Drug‐Induced QT Prolongation: Assessment by Different Recording and Measurement Methods (2004) (99)
- Update on Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on QT Interval, Left Ventricular Dysfunction and Overall Risk/Benefit (2015) (92)
- Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group. (1996) (92)
- Noninvasive evaluation of normal and abnormal prosthetic valve function. (1983) (91)
- Acute severe aortic regurgitation. Pathophysiology, clinical recognition, and management. (1977) (91)
- Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms. (1993) (88)
- The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty. (1992) (87)
- Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event. (1993) (87)
- A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia. (2005) (85)
- Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery. (1978) (85)
- Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapy. (1989) (83)
- Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy. (1989) (82)
- Treatment of hyperlipidemia. (1974) (78)
- Evaluation of vardenafil and sildenafil on cardiac repolarization. (2004) (74)
- Ethmozin: a new antiarrhythmic agent developed in the USSR. Efficacy and tolerance. (1979) (73)
- Retinal arteriolar changes as an indicator of coronary artery disease. (1979) (71)
- Premature ventricular complexes. Diagnosis and indications for therapy. (1984) (70)
- Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular function. (1985) (68)
- Application of a frequency definition of ventricular proarrhythmia. (1987) (66)
- Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects (2002) (66)
- Diagnostic accuracy of seismocardiography compared with electrocardiography for the anatomic and physiologic diagnosis of coronary artery disease during exercise testing. (1993) (63)
- Influence of left ventricular dysfunction on flecainide therapy. (1987) (63)
- Detecting Left Main Coronary Artery Disease by Apical, Cross‐sectional Echocardiography (1980) (62)
- Effects of a New Antibacterial, Telavancin, on Cardiac Repolarization (QTc Interval Duration) in Healthy Subjects (2004) (61)
- The use of the Doppler stethoscope in the evaluation of varicoceles. (1977) (58)
- Apical cross-sectional echocardiography. Standard for the diagnosis of idiopathic mitral valve prolapse syndrome. (1981) (57)
- R‐wave Amplitude Variations During Acute Experimental Myocardial Ischemia: An Inadequate Index for Changes in Intracardiac Volume (1981) (56)
- The value of echocardiographic regional wall motion abnormalities in detecting coronary artery disease in patients with or without a dilated left ventricle. (1985) (56)
- Cardiac hypertrophy in response to dynamic conditioning in female athletes. (1978) (55)
- Treatment of ventricular arrhythmias by United States cardiologists: a survey before the Cardiac Arrhythmia Suppression Trial results were available. (1990) (54)
- Bupivacaine Extended-Release Liposome Injection Exhibits a Favorable Cardiac Safety Profile (2011) (54)
- Cardiac Repolarization and the Safety of New Drugs Defined by Electrocardiography (2007) (53)
- A definitive or thorough phase 1 QT ECG trial as a requirement for drug safety assessment. (2004) (52)
- Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. (1986) (51)
- Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease (COPD): Occurrence Frequency and the Effect of Treatment With the Inhaled Long-Acting Beta2-Agonists Arformoterol and Salmeterol (2008) (51)
- THE ATHLETE'S HEART SYNDROME: A NEW PERSPECTIVE (1977) (48)
- SV40 Virus-induced Tumour Specific Transplantation Antigen in Cultured Mouse Cells (1970) (48)
- Exercise performance after septal myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy. (1979) (48)
- Fascicular conduction disturbances after coronary bypass surgery (1978) (48)
- Echocardiographic features of atrioventricular and ventriculoatrial conduction. (1980) (47)
- Electrocardiographic Effects of Rivastigmine (2002) (46)
- Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis. (1983) (45)
- Identification of sotalol-induced changes in repolarization with T wave area-based repolarization duration parameters. (2003) (44)
- Tricuspid regurgitation: noninvasive techniques for determining causes and severity. (1984) (43)
- Cibenzoline plasma concentration and antiarrhythmic effect (1984) (42)
- The Evaluation of New Antiarrhythmic Drugs (1981) (41)
- Pseudohomozygous type II hyperlipoproteinemia. (1974) (39)
- Proarrhythmia, arrhythmogenesis or aggravation of arrhythmia--a status report, 1987. (1987) (39)
- Relationship of atrial fibrillatory wave amplitude to left atrial size and etiology of heart disease. An old generalization re-examined. (1979) (39)
- Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmias. (1985) (38)
- Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial. (1996) (38)
- Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients. (1991) (37)
- Focus on issues in measuring and interpreting changes in the QTc interval duration (2001) (37)
- Ambulatory Holter electrocardiography: choice of technologies and clinical uses. (1985) (37)
- Evaluation and Management of Cardiac Safety Using the Electrocardiogram in Oncology Clinical Trials: Focus on Cardiac Repolarization (QTc Interval) (2010) (36)
- No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines. (2010) (36)
- Clinical Experience with Moxifloxacin in Patients with Respiratory Tract Infections (2004) (36)
- QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial. (2021) (36)
- Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development. (2004) (32)
- A review of the cardiac systemic side‐effects of antihistamines: ebastine (1999) (32)
- Single‐Dose Pharmacokinetics and Dose Proportionality of Oral Cibenzoline (1984) (32)
- Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine). (1989) (32)
- A new approach to visualize the left main coronary artery using apical cross-sectional echocardiography. (1980) (32)
- Effects of Food on the Bioequivalence of Different Verapamil Sustained‐Release Formulations (1995) (31)
- Comparative efficacy and tolerance of esmolol to propranolol for control of supraventricular tachyarrhythmia. (1985) (30)
- Unsuspected substantial pericardial effusions detected by echocardiography. (1976) (30)
- Pharmacologic management of ventricular arrhythmias after the cardiac arrhythmia suppression trial. (1990) (28)
- The Evaluation of Beta Blocker and Calcium Antagonist Drugs (1982) (28)
- Effect of single ascending, supratherapeutic doses of sparfloxacin on cardiac repolarization (QTc interval). (1999) (28)
- Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias. (1987) (27)
- Early Investigation of QTc Liability (2012) (26)
- Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval. (2001) (26)
- Sudden death during ambulatory electrocardiographic monitoring. (1991) (26)
- Effects of the Selective α1A‐Adrenoceptor Antagonist Silodosin on ECGs of Healthy Men in a Randomized, Double‐Blind, Placebo‐ and Moxifloxacin‐Controlled Study (2010) (26)
- A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent. (1985) (25)
- Early investigation of QTc liability: the role of multiple ascending dose (MAD) study. (2012) (25)
- Cardiac Effects of Ebastine and Other Antihistamines in Humans (1999) (25)
- Cardiac safety of noncardiac drugs : practical guidelines for clinical research and drug development (2005) (25)
- 1156 POSTER High dose palonosetron does not alter ECG parameters including QTc interval in healthy subjects: results of a dose-response, double blind, randomized, parallel E14 study of palonosetron vs. moxifloxacin or placebo (2007) (24)
- The Pharmacokinetics and Safety of Single Escalating Oral Doses of Eletriptan (2002) (23)
- Dose-response range of encainide for benign and potentially lethal ventricular arrhythmias. (1986) (23)
- Early recognition of surgically correctable causes of excessive mediastinal bleeding after coronary artery bypass graft surgery. (1980) (23)
- Short‐ and Long‐Term Therapeutic Efficacy of Quinidine Sulfate for the Treatment of Chronic Ventricular Arrhythmias (1982) (23)
- Pharmacokinetics of moricizine HCl. (1987) (23)
- Can we prevent sudden cardiac death? (1982) (23)
- Initiating events of sudden cardiac death. (1985) (22)
- Differentiation of carcinomatous and bacterial meningitis (1972) (21)
- How to Obtain and Analyze Electrocardiograms in Clinical Trials (1999) (21)
- Fixed coupling: different mechanisms revealed by exercise-induced changes in cycle length. (1978) (21)
- Eletrocardiographic Monitoring in COPD Patients Receiving Tiotropium (2004) (21)
- Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplasty. (1991) (21)
- Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone. (1987) (20)
- Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers (2012) (20)
- Tocainide: a new oral antiarrhythmic agent. (1985) (20)
- Quinidine-induced liver disease. (1972) (20)
- The cardiac pharmacodynamics of therapeutic doses of sparfloxacin. (1999) (20)
- Antiarrhythmic effects of beta-adrenergic blocking agents in benign or potentially lethal ventricular arrhythmias. (1987) (20)
- Silent myocardial ischemia as a mechanism of sudden cardiac death. (1986) (20)
- Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery. (1984) (20)
- Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials (2017) (20)
- Antiarrhythmic agents and their use in therapy. (1980) (19)
- Apex sector echocardiography in evaluation of the right atrium in patients with mitral stenosis and atrial septal defect. (1978) (19)
- New Criteria to Enhance the Predictability of Coronary Artery Disease by Exercise Testing in Asymptomatic Subjects (1977) (19)
- Tricuspid valve prolapse diagnosed by cross-sectional echocardiography. (1981) (19)
- Cross-sectional echocardiographic detection of aortic valve prolapse. (1980) (18)
- Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study. (2015) (18)
- Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana? (1987) (18)
- Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia. (1986) (18)
- Proarrhythmic effects of antiarrhythmic drugs: evolving concepts. (1992) (18)
- Determinants of Ventricular Septal Motion: Influence of Relative Right and Left Ventricular Size (1976) (18)
- Prediction of cardiac death in patients with a very low ejection fraction after myocardial infarction: a Cardiac Arrhythmia Suppression Trial (CAST) study. (1995) (17)
- Encainide for ventricular arrhythmias: placebo-controlled and standard comparison trials. (1986) (17)
- The cardiokymography exercise test compared to the thallium-201 perfusion exercise test in the diagnosis of coronary artery disease. (1984) (17)
- Tricuspid regurgitation in tricuspid valve prolapse demonstrated with contrast cross-sectional echocardiography. (1980) (17)
- Isolated dextroversion of the heart with asymmetric septal hypertrophy. (1976) (17)
- Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias. (1984) (16)
- Echocardiographic detection of coronary artery disease. Detection of effects of ischemia on regional myocardial wall motion and visualization of left main coronary artery disease. (1980) (16)
- Dilated cardiomyopathy in the idiopathic hypereosinophilic syndrome. (1983) (16)
- Effects of intravenous infusion of esmolol and propranolol on biventricular performance at rest and during exercise as assessed by quantitative radionuclide angiography. (1985) (16)
- Cardiac Safety of Noncardiac Drugs (2005) (15)
- Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia (1990) (15)
- Acute severe mitral regurgitation. Pathophysiology, clinical recognition, and management. (1985) (15)
- Effect of single doses of IV palonosetron, up to 2.25 mg, on the QTc interval duration: a double-blind, randomized, parallel group study in healthy volunteers (2015) (15)
- Myocardial oxygen supply/demand ratio in aortic stenosis: hemodynamic and echocardiographic evaluation of patients with and without angina pectoris. (1983) (15)
- Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study (2013) (14)
- The clinical electrophysiology of intravenous indecainide. (1985) (14)
- Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias. (1985) (14)
- Interventions in the Acute Phase of Myocardial Infarction (2011) (14)
- ICH E14 Q & A (R1) document: perspectives on the updated recommendations on thorough QT studies. (2013) (14)
- Rheumatic mitral stenosis:cross-sectional echocardiographic analysis. (1980) (14)
- New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the cardiac arrhythmia suppression trial and its pilot study (1994) (13)
- Cholestyramine: an effective, twice-daily dosage regimen. (1976) (13)
- A Thorough Electrocardiogram Study of Edoxaban, a Novel Factor Xa Inhibitor (2011) (12)
- Evaluation of antiarrhythmic therapy using Holter monitoring. (1988) (12)
- Ambulatory electrocardiographic monitoring in the evaluation of new antiarrhythmic drugs. (1986) (12)
- Comparative efficacy and safety of short-acting and sustained release quinidine in the treatment of patients with ventricular arrhythmias. (1985) (12)
- Lack of Effect of Azelastine and Ketoconazole Coadministration on Electrocardiographic Parameters in Healthy Volunteers (1997) (12)
- ICH E14 Q&A(R2) document: commentary on the further updated recommendations on thorough QT studies. (2015) (12)
- Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents (2011) (12)
- Evaluation of the effect on cardiac repolarization (QTc interval) of oncologic drugs. (2007) (11)
- Replacing the thorough QT study: reflections of a baby in the bath water. (2014) (11)
- Electrocardiographic evidence of left ventricular hypertrophy in otherwise normal children. Clarification by echocardiography. (1975) (11)
- Evaluating the QT-Liability of a Drug during its Development (2008) (11)
- Computer Recognition of Cardiac Arrhythmias and Statistical Approaches to Arrhythmia Analysis (1984) (11)
- The syndromes of familial atrioventricular block with sinus bradycardia: prognostic indices, electrophysiologic and histopathologic correlates. (1978) (11)
- Prosthetic mitral valve motion during cardiac dysrhythmias as determined by echocardiography. (1983) (11)
- Long-Term Ambulatory Electrocardiographic Recording in the Determination of Efficacy of New Antiarrhythmic Agents (1981) (10)
- Ambulatory ischemia and sudden death: An analysis of 35 cases of death during ambulatory ECG monitoring (1991) (10)
- Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment (1983) (10)
- Holter monitoring and sudden cardiac death (1992) (10)
- Systemic concentrations of salbutamol and HFA-134a after inhalation of salbutamol sulfate in a chlorofluorocarbon-free system. (1996) (10)
- Oral verapamil in the treatment of atrial fibrillation/flutter (1982) (10)
- Limitations of infrequent holter monitoring in assessing antiarrhythmic efficacy (1978) (10)
- Idiopathic left ventricular hypertrophy. (1974) (10)
- Cardiac Arrhythmias: New Therapeutic Drugs and Devices (1985) (10)
- Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias. (1985) (9)
- Dose effect of moricizine on suppression of ventricular arrhythmias. (1990) (9)
- Beta Blocking Agents in the Treatment of Ventricular Arrhythmias (1982) (9)
- The effects of benazepril, a new angiotensin‐converting enzyme inhibitor, in mild to moderate essential hypertension: A multicenter study (1991) (9)
- Infective endocarditis involving a presumably normal pulmonic valve. (1984) (8)
- The cooperative encainide trial: Efficacy, tolerance and dose findings in chronic severe ventricular ectopy (1982) (8)
- Effect of orally administered celiprolol in patients with chronic atrial fibrillation. (1986) (8)
- Double-blind comparison of doxazosin, nadolol, and placebo in patients with mild-to-moderate hypertension (1988) (8)
- Safety and efficacy of a twice-daily dosing regimen for moricizine (ethmozine). (1985) (8)
- Embolized disc from a Beall mitral valve prosthesis. Real-time echocardiographic identification. (1982) (8)
- Antiarrhythmic drug therapy 1988: for whom, how and where? (1988) (8)
- Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials. (1987) (8)
- Sensitivity in detecting drug-induced alterations in the PR interval: comparison of the surface electrocardiogram measured by a cardiologist versus routine automated computer analysis. (1993) (8)
- Discrete fibromembranous aortic stenosis in middle age. Natural history and case report. (1979) (7)
- 734: Cardiovascular Safety of the Combination of Vardenafil and Alpha-Blockers: A Subgroup Analysis of the Post Marketing Surveillance Study ‘Real Life Safety and Efficacy of Vardenafil (Realise) (2005) (7)
- Familial type III hyperlipoproteinemia. (1977) (7)
- Changes in the Corneal Reflex in Patients Wearing Contact Lenses (1969) (7)
- Acute severe pulmonic valve regurgitation: pathophysiology, diagnosis, and treatment. (1984) (6)
- Efficacy of oral and intravenous indecainide in ventricular arrhythmias. (1987) (6)
- Ischemia at rest is independent of the extent of ventricular dysfunction and arrhythmias in patients with coronary artery disease. (1985) (6)
- Discrepancy between the QRS scoring system and left ventricular ejection fraction after surgical or medical revascularization during acute myocardial infarction. (1984) (6)
- A definitive study of the effects of PDE‐5 inhibitors on cardiac repolarization in middle‐age males (2004) (5)
- Flecainide vs quinidine: Efficacy and tolerance in patients with chronic stable ventricular ectopy (1982) (5)
- The effect of terfenadine on the cardiac pharmacodynamics of sparfloxacin. (1999) (5)
- A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease (2019) (5)
- How to Evaluate a New Antiarrhythmic Drug: The Challenge of Sudden Cardiac Death (1981) (5)
- Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment. (1986) (5)
- Superior QRS axis of ventricular premature complexes: an additional criterion to enhance the sensitivity of exercise stress testing. (1980) (4)
- Noninvasive diagnosis of the cardiomyopathies. (1980) (4)
- Atrial alternans: experimental echocardiographic and hemodynamic demonstration during programmed pacing. (1981) (4)
- Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias. (1984) (4)
- New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study. The CAST and CAPS Investigators. (1994) (4)
- Bepridil hydrochloride for treatment of benign or potentially lethal ventricular arrhythmias. (1986) (4)
- Response to “Design of the ‘Thorough QT Study’” (2008) (4)
- Noninvasive approaches to cardiac imaging: comparisons and contrasts. (1980) (4)
- Design and Conduct of the Thorough Phase I ECG Trial for New Bioactive Drugs (2005) (4)
- Antiarrhythmic effect of a 5-hydroxytryptamine M-receptor antagonist, ICS 205-930. (1988) (4)
- Effectiveness of low-dose nadolol for ventricular arrhythmias. (1986) (4)
- Sensitivity to atypical mycobacterial antigens in patients with Crohn's disease (1970) (4)
- New Antiarrhythmic Drugs (1988) (4)
- Early and late proarrhythmia from antiarrhythmic drug therapy (1992) (4)
- New concepts in cardiac imaging 1985 (1985) (3)
- Large mobile pedunculated left ventricular thrombus: Identification by two‐dimensional echocardiography (1981) (3)
- Placement of moricizine in the selection of antiarrhythmic drug therapy. (1990) (3)
- Proarrhythmic potential of reverse use-dependent drugs. (2007) (3)
- Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens (2022) (3)
- A Practical Approach to Cardiac Safety Implementing ICH E 14 to define cardiac safety in new drug development (3)
- Cellular and humoral sensitivity to gluten fractions in patients with treated nontropical sprue (1972) (3)
- New antiarrhythmic agents: mexiletine, tocainide, encainide, flecainide, and amiodarone. (1987) (3)
- Benefits of Centralized ECG Reading in Clinical Oncology Studies (2016) (3)
- Oral antiarrhythmic agents for ventricular arrhythmias. (1986) (3)
- Two Dimensional Echocardiography in Acute Myocardial Infarction: Clinical Applications (1984) (3)
- Sudden Cardiac Death (1985) (3)
- Tegaserod, a 5HT4 receptor partial agonist, devoid of significant electrocardiographic effects (2001) (2)
- Laboratory findings in pulmonary embolism. (1971) (2)
- Prevention of restenosis after PTCA by angiotensin converting enzyme inhibitors (1991) (2)
- The ventricular premature complex. (1984) (2)
- Calcification of the tricuspid anulus diagnosed by two-dimensional echocardiography. (1984) (2)
- A rational approach to the planning and analysis of electrocardiogram safety data in clinical trials (2002) (2)
- Drug-induced early and late proarrhythmia. (1992) (2)
- Fascicular conduction distrubances after coronary bypass surgery. (1978) (2)
- Remote Data Entry and the Electronic New Drug Application: An Integrated Approach to Acquire, Analyze, and Review New Drug Data (1987) (2)
- Electrocardiographic response to intravenous and intraarterial injection of iosimenol (a new, iodinated, non-ionic, iso-osmolar contrast medium). (2013) (2)
- Intravenous atenolol for ventricular arrhythmias. (1986) (2)
- Thallium-201 imaging in pericardial effusion. (1986) (2)
- Congestive heart failure and ventricular arrhythmias. (1988) (2)
- Noninvasive testing for ventricular arrhythmias. (1988) (2)
- Management of ventricular arrhythmias in patients with congestive heart failure. Second case history presentation and panel discussion. (1986) (2)
- A noninvasive perspective of electrophysiologic testing. (1986) (1)
- Asymptomatic Coronary Artery Disease: Angiographic Assessment ofDiabetics Evaluated forRenalTransplantation (1978) (1)
- Use of claims data for determining the appropriateness of ambulatory cardiac monitoring. (1993) (1)
- The athlete's heart syndrome. A new prospective (1977) (1)
- The contributions of ambulatory ECG. (1979) (1)
- S1033 Results of a Thorough QT Study (ICH E14) Testing a Novel Gastrointestinal Prokinetic, ATI-7505, Show NO ECG Effects at Therapeutic and Supra-Therapeutic Doses (2010) (1)
- THE EFFECT OF TWICE-DAILY NEBULIZED ARFORMOTEROL ON QTC IN SUBJECTS WITH COPD (2007) (1)
- Noninvasive cardiac imaging (1983) (1)
- Mechanisms sustaining diastolic mitral valve “locking” (1982) (1)
- Cardiovascular drug therapy (1986) (1)
- Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma (2015) (1)
- The assessment of the right atrium using apex-sector echocardiography (1978) (1)
- Ambulatory management of ventricular arrhythmias. (1980) (1)
- Class IC Antiarrhythmic Agents: Status — 1984 (1985) (1)
- Overview: moricizine--can it meet the challenge? (1990) (1)
- Flecainide: a new antiarrhythmic agent. (1986) (1)
- Antiarrhythmic agents for chronic ventricular arrhythmias. (1987) (1)
- Can intracardiac volume changes adequately explain R-wave variations associated with acute coronary ischemia? (1980) (1)
- The significance of biphasic R wave amplitude changes during incremental atrial pacing: A sensitive and specific marker for acute myocardial ischemia (1981) (1)
- Modulation of Cytotoxic T Lymphocyte Function by Cyclic 3′,5′-Mononucleotides (1974) (1)
- Noninvasive cardiac imaging: echocardiography. (1982) (1)
- Does idiopathic left ventricular typertrophy exist (1974) (1)
- Indications for antiarrhythmic suppression of ventricular arrhythmias: a definition of life-threatening ventricular arrhythmias. (1993) (1)
- Ventricular arrhythmias. Clinical recognition and management. (1984) (1)
- Class IV Antiarrhythmic Agents: Utility in Supraventricular Arrhythmias and Their Proarrhythmic Potential (1989) (1)
- Study Design for Patients with Chronic Ventricular Ectopy: Determination Of Efficacy And Tolerance (1983) (1)
- The Evaluation of new antiarrhythmic drugs : proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug: the Evaluation of New Antiarrhythmic Agents for the Treatment of Ventricular Arrhythmias, held at Philadelphia, Pennsylvania, October 8-9, 1980 (1981) (1)
- Increased mortality from quinidine therapy in the treatment of ventricular arrhythmias (1991) (1)
- Silent myocardial ischemia : proceedings of the Symposium on New Drugs and Devices, October 15-16, 1987, Philadelphia, Pa. (1988) (0)
- Noninvasive Evaluation of Proarrhythmia (1987) (0)
- Spontaneous variability in arrhythmia frequency. (1979) (0)
- Signal-averaged electrocardiography and ambulatory monitoring : Diagnosis (1991) (0)
- Signal-averaged electrocardiography and ambulatory monitoring. (1992) (0)
- Acute Severe Aortic Regurgitation (2020) (0)
- Short Term Evaluation of Atenolol in Hospitalised Patients with Chronic Ventricular Arrhythmias (1983) (0)
- Summary II: Implications for therapy in arrhythmias (1985) (0)
- New therapy update (1986) (0)
- Identification of the Patient at High Risk of Sudden Cardiac Death (1983) (0)
- Management of arrhythmias in ischemic heart disease. The role of beta blockers. (1988) (0)
- Tu1478 Ulimorelin, a Ghrelin Receptor Agonist, Represents a New Class of Promotility Drugs Without QTc Prolongation: Results of a Thorough ECG Evaluation (2012) (0)
- Role of Beta-Blocking Agents in the Treatment of Ventricular Arrhythmias (1985) (0)
- Variant human lipoprotein electrophoretic patterns (1970) (0)
- Comparative Evaluation of Àntiarrhythmic Agents (2012) (0)
- First case history presentation and panel discussion (1986) (0)
- Echocardiography in the diagnosis and quantification of valvular heart disease. (1983) (0)
- Pulmonary venous regurgitation: Etiology of hemodynamic deterioration during ventricular tachyarrhythmias and pacing (1980) (0)
- Panel on Indices to Define Infarct Size (1984) (0)
- General Group Discussion: Holter Monitoring (1981) (0)
- Editorial Review Drug-Induced Cardiac Toxicity: Emphasizing the Role of Electrocardiography in Clinical Research and Drug Development (2004) (0)
- Differential utility of antiarrhythmic agents. (1987) (0)
- Cardiac arrhythmias : new therapeutic drugs and devices : proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 4 and 5, 1984 (1985) (0)
- Influence of left atrial size and age on the development of atrial fibrillation in patients with mitral valve disease and asymmetric septal hypertrophy (1975) (0)
- Drug-Induced Enhanced Risk for Sudden Cardiac Death in Clinical Practice, Clinical Research, and Drug Development (2008) (0)
- Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents : proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 (1989) (0)
- What are the Recommendations to the Medical Community to Institute Hypolipidemic Therapy (1989) (0)
- Efficacy Models for Patients with Chronic Ventricular Arrhytmias (1983) (0)
- Determination of antiarrhythmic drug efficacy in the treatment of ventricular arrhythmias (1990) (0)
- Ventricular arrhythmias: current concepts. (1984) (0)
- General Group Discussion — Problems in Study Design (1982) (0)
- Sudden cardiac death and congestive heart failure : diagnosis and treatment : proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 26 and 27, 1982 (1983) (0)
- A Phase I Study of Midostaurin (PKC412) Investigating Cardiac Interval Effects In Healthy Subjects (2010) (0)
- Management of ventricular arrhythmias in patients with congestive heart failure. First case history presentation and panel discussion. (1986) (0)
- General Group Discussion: Study Designs: Chronic Patients (1981) (0)
- New Insights into the Drug Treatment of Ventricular Arrhythmias (1984) (0)
- Safety and Value of Maximal Predischarge Exercise Stress Testing Early After Myocardial Infarction. (1992) (0)
- Congestive heart failure : proceedings of the Symposium on New Drugs and Devices, October 30-31, 1986, Philadelphia, Pennsylvania (1987) (0)
- Tegaserod of its Use in the Management of Irritable Bowel Syndrome with Constipation in Women (2003) (0)
- Effect of alosetron versus placebo on QTC interval duration in healthy females (2000) (0)
- Mean Hourly Ventricular Monitoring Periods Premature Depolarization Frequency for Each of Three 24-Hour Control 3 Day Patient * Age Sex Diagnosis Day 1 Day 2 Day (0)
- The effect of tivantinib on QTc interval in subjects with advanced solid tumors and healthy subjects. (2014) (0)
- The clinical bases of exercise stress testing. (1977) (0)
- Do Beta Blockers Prevent Sudden Cardiac Death (1983) (0)
- Are there unnecessary delays in the development of new cardiac drugs in the United States? (1986) (0)
- Wide-complex tachycardias: recognition and management. (1988) (0)
- EFFECT OF PROPRANOLOL ON VENTRICULAR ARRHYTHMIA/Lichstein et al (2005) (0)
- Second case history presentation and panel discussion (1986) (0)
- Echocardiography in the Differential Diagnosis of Patients with Chest Pain (1988) (0)
- 7 – The Pharmacology of Antiarrhythmic Drugs (1986) (0)
- Diastolic Murmur of Complete Heart Block (2005) (0)
- Idiopathic Mitral Valve Prolapse Syndrome (2017) (0)
- Influence of Left Ventricular Dysfunctlon on Flecainide Therapy (2010) (0)
- Panel on Pharmaceutical Interventions to Reduce Infarct Size (continued) (1984) (0)
- Clinical echocardiography. (1975) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Joel Morganroth?
Joel Morganroth is affiliated with the following schools:
